A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center ...

In this article we will test a trading system based on a trend-following breakout logic, applied to one of the world's most famous and most traded indexes, the Nasdaq. Since we are trading the CME ...

Rb1 loss may serve as a predictive biomarker to guide new targeted therapies for select breast cancers resistant to standard ...

In June 2022 ATR become the first to fly a commercial aircraft with 100% SAF in both engines and it is targeting 2025 for 100% SAF readiness. Credit: ATR ATR recently published a summary of its ...

"Our goal in the LATIFY trial was to reinvigorate the immune response of patients with lung cancer whose tumours stopped ...

There have been numerous unexpected changes recently to ATR’s environment—in geopolitics, competition and customer fleet policy. Meanwhile, some anticipated changes in foreign regulations and within ...

CEO Phillip Chan highlighted a 25% growth in Q4 product revenue, reaching $9.2 million, and $35.6 million in total product revenue for 2024, representing a 15% annual growth. He emphasized strong ...

Among an array of aircraft models in ATR chief executive Christian Scherer's office – mostly of Airbus jets, which is no surprise given his three decades at the European consortium – one takes pride ...

A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer ...